128 related articles for article (PubMed ID: 9013909)
1. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses.
Westerband A; Mills JL; Marek JM; Heimark RL; Hunter GC; Williams SK
J Vasc Surg; 1997 Jan; 25(1):64-73. PubMed ID: 9013909
[TBL] [Abstract][Full Text] [Related]
2. Topography of cell replication in human vein graft stenoses.
Westerband A; Mills JL; Hunter GC; Gentile AT; Ihnat D; Heimark RL
Circulation; 1998 Nov; 98(19 Suppl):II325-9; discussion II329-30. PubMed ID: 9852922
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity in stenotic human aortocoronary bypass grafts.
Hilker M; Tellmann G; Buerke M; Gloger K; Moersig W; Oelert H; Hake U; Lehr HA
Cardiovasc Pathol; 2002; 11(5):284-90. PubMed ID: 12361839
[TBL] [Abstract][Full Text] [Related]
4. Bypass graft disease: analysis of proliferative activity in human aorto-coronary bypass grafts.
Hilker M; Buerke M; Lehr HA; Oelert H; Hake U
Heart Surg Forum; 2002; 5 Suppl 4():S331-41. PubMed ID: 12759206
[TBL] [Abstract][Full Text] [Related]
5. Vein adaptation to arterialization in an experimental model.
Westerband A; Crouse D; Richter LC; Aguirre ML; Wixon CC; James DC; Mills JL; Hunter GC; Heimark RL
J Vasc Surg; 2001 Mar; 33(3):561-9. PubMed ID: 11241128
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses.
Gentile AT; Mills JL; Westerband A; Gooden MA; Berman SS; Boswell CA; Williams SK
Cardiovasc Surg; 1999 Jun; 7(4):464-9. PubMed ID: 10430532
[TBL] [Abstract][Full Text] [Related]
7. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts.
Kockx MM; Cambier BA; Bortier HE; De Meyer GR; Declercq SC; van Cauwelaert PA; Bultinck J
Histopathology; 1994 Oct; 25(4):365-71. PubMed ID: 7835842
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of threshold criteria for intervention in infrainguinal vein grafts undergoing duplex surveillance.
Westerband A; Mills JL; Kistler S; Berman SS; Hunter GC; Marek JM
Ann Vasc Surg; 1997 Jan; 11(1):44-8. PubMed ID: 9061138
[TBL] [Abstract][Full Text] [Related]
9. The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance.
Mills JL; Bandyk DF; Gahtan V; Esses GE
J Vasc Surg; 1995 Jan; 21(1):16-22; discussion 22-5. PubMed ID: 7823355
[TBL] [Abstract][Full Text] [Related]
10. Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience.
Idu MM; Blankenstein JD; de Gier P; Truyen E; Buth J
J Vasc Surg; 1993 Jan; 17(1):42-52; discussion 52-3. PubMed ID: 8421341
[TBL] [Abstract][Full Text] [Related]
11. Do normal early color-flow duplex surveillance examination results of infrainguinal vein grafts preclude the need for late graft revision?
Passman MA; Moneta GL; Nehler MR; Taylor LM; Edwards JM; Yeager RA; McConnell DB; Porter JM
J Vasc Surg; 1995 Oct; 22(4):476-81; discussion 482-4. PubMed ID: 7563409
[TBL] [Abstract][Full Text] [Related]
12. Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy.
Armstrong PA; Bandyk DF; Wilson JS; Shames ML; Johnson BL; Back MR
J Vasc Surg; 2004 Oct; 40(4):724-30; discussion 730-1. PubMed ID: 15472601
[TBL] [Abstract][Full Text] [Related]
13. Surgical and endovascular intervention for infrainguinal vein graft stenosis.
Avino AJ; Bandyk DF; Gonsalves AJ; Johnson BL; Black TJ; Zwiebel BR; Rahaim MJ; Cantor A
J Vasc Surg; 1999 Jan; 29(1):60-70; discussion 70-1. PubMed ID: 9882790
[TBL] [Abstract][Full Text] [Related]
14. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
15. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five-year prospective study.
Mills JL; Fujitani RM; Taylor SM
J Vasc Surg; 1993 Jan; 17(1):195-204; discussion 204-6. PubMed ID: 8421336
[TBL] [Abstract][Full Text] [Related]
16. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program.
Carter A; Murphy MO; Halka AT; Turner NJ; Kirton JP; Murray D; Bodill H; Millar ML; Mason T; Smyth JV; Walker MG
Ann Vasc Surg; 2007 Nov; 21(6):695-703. PubMed ID: 17980793
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation in human arteriovenous fistulas used for hemodialysis.
Rekhter M; Nicholls S; Ferguson M; Gordon D
Arterioscler Thromb; 1993 Apr; 13(4):609-17. PubMed ID: 8096766
[TBL] [Abstract][Full Text] [Related]
18. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
[TBL] [Abstract][Full Text] [Related]
19. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts.
Zhang WD; Bai HZ; Sawa Y; Yamakawa T; Kadoba K; Taniguchi K; Masuda J; Ogata J; Shirakura R; Matsuda H
J Vasc Surg; 1999 Jul; 30(1):169-83. PubMed ID: 10394167
[TBL] [Abstract][Full Text] [Related]
20. In vivo vascular engineering of vein grafts: directed migration of smooth muscle cells by perivascular release of elastase limits neointimal proliferation.
Amabile PG; Wong H; Uy M; Boroumand S; Elkins CJ; Yuksel E; Waugh JM; Dake MD
J Vasc Interv Radiol; 2002 Jul; 13(7):709-15. PubMed ID: 12119330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
